Journal of Pharmaceutical Care & Health Systems
Open Access

Jerry Altshuler

Publications

• Research Article
  Risk Factors for Bleeding Events with Enoxaparin, Dabigatran and Fondaparinux in Hospitalized Patients with Varying Levels of Renal Impairment
  Author(s): Tania Ahuja, Jerry Altshuler and John Papadopoulos Tania Ahuja, Jerry Altshuler and John Papadopoulos
  
  Background: Anticoagulants with renal elimination may accumulate in patients with renal impairment and potentially increase the risk of bleeding. Limited data are available to elucidate the potential bleeding risk present in patients with moderate renal impairment defined as creatinine clearance of 30-50 mL/min. Objective: To evaluate potential risk factors for bleeding over various renal function ranges in patients on enoxaparin, fondaparinux, or dabigatran. Methods: Retrospective chart review from 2010 until 2011 identified patients who incurred a bleeding episode on therapeutic dosed enoxaparin, dabigatran, or fondaparinux stratified according to renal function and presence of pre-defined potential risk factors for bleeding. Bleeding episodes identified using UHC Safety Intelligence, a selfreporting database use.. View More»
  DOI: 10.4172/2376-0419.1000178

  Abstract PDF

Relevant Topics